A/Prof David Bossingham ~ JCU Associate Professor

Undergraduate at St Marys Hospital, University of London, MB BS 1972

Postgraduate training at the Clinical Research Centre, London and at Oxford, Nuffield Orthopaedic Centre and Nuffield Department of Medicine

Consultant Rheumatologist to the Nottingham Hospitals. Clinical Teacher Nottingham University, Honorary Lecturer School of Pharmacy, Nottingham University

Clinical Tutor Nottingham City Hospital

Rheumatologist and Physician in Cairns since 1992

Diector of Clinical Training, Cairns Base Hospital, 1995-2000

I started teaching Medical students in 1976 during my training in Oxford. My researches have taken me to various areas including Clinical Immunology, Biomechanics, Rehabilitation, Psychology, Virology, Epidemiology and The History Of Medicine as well as Clinical Rheumatology.

Research Disciplines

• Epidemiology (4202)
• Bioinformatics and computational biology (3102)
• Genetics (3105)

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Abbot S, McWilliams L, Spargo L, De Costa C, Ur-Rehman Z, Proudman S and Bossingham D (2020) Scleroderma in Cairns: an epidemiological study. Internal Medicine Journal, 50 (4). pp. 445-452
• Singh M, Jackson K, Wang J, Schofield P, Field M, Koppstein D, Peters T, Burnett D, Rizzetto S, Nevoltris D, Masle-Farquhar E, Faulks M, Russell A, Gokal D, Hanioka A, Horikawa K, Colella A, Chataway T, Blackburn J, Mercer T, Langley D, Goodall D, Jefferis R, Komala M, Kelleher A, Suan D, Rischmueller M, Christ D, Brink R, Luciani F, Gordon T, Goodnow C and Reed J (2020) Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell, 180 (5). pp. 878-894
• Hall S, Nash P, Rischmueller M, Bossingham D, Bird P, Cook N, Witcombe D, Soma K, Kwok K and Thirunavukkarasu K (2018) Tofacitinib, an oral janus kinase inhibitor: pooled efficacy and safety analyses in an Australian rheumatoid arthritis population. Rheumatology and Therapy, 5 (2). pp. 383-401
• Vincent F, Bourke P, Morand E, Mackay F and Bossingham D (2013) Focus on systemic lupus erythematosus in Indigenous Australians: towards a better understanding of autoimmune diseases. Internal Medicine Journal, 43 (3). pp. 227-234
• Mason J and Bossingham D (2009) The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred. Lupus, 18 (2). pp. 144-148
• Bossingham D (2006) Ross River fever. Medicine Today, 7 (1). pp. 49-50
• Goodman D, Morrissey S, Graham D and Bossingham D (2005) Illness representations of Systemic lupus erythematosus. Qualitative Health Research, 15 (5). pp. 606-619
• Goodman D, Morrissey S, Graham D and Bossingham D (2005) The application of cognitive-behaviour therapy in altering illness representations of Systemic Lupus Erythematosus. Behaviour Change, 22 (3). pp. 156-171
• Harley D, Bossingham D, Purdie D, Pandeya N and Sleigh A (2002) Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Medical Journal of Australia, 177 (7). pp. 352-355

Other research outputs

• Bossingham D (2011) Myalgia and fatigue after Ross River virus disease. Medicine Today, 12 (5). pp. 70-72

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.